Clinical	O
Experience	O
With	O
the	O
Subcutaneous	O
Implantable	O
Cardioverter	O
-	O
Defibrillator	O
in	O
Adults	O
With	O
Congenital	B:C0152021
Heart	I:C0152021
Disease	I:C0152021
.	O

Sudden	B:C0085298
cardiac	I:C0085298
death	I:C0085298
is	O
a	O
major	O
contributor	O
to	O
mortality	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
.	O

Sudden	O
cardiac	I:C0085298
death	I:C0085298
is	O
a	O
major	O
contributor	O
to	O
mortality	O
for	O
adults	O
with	O
congenital	B:C0152021
heart	I:C0152021
disease	I:C0152021
.	O

The	O
subcutaneous	B:C0443315
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
(	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
)	O
has	O
emerged	O
as	O
a	O
novel	O
tool	O
for	O
prevention	O
of	O
sudden	O
cardiac	I:C0085298
death	I:C0085298
,	O
but	O
clinical	O
performance	I:C3266594
data	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
are	O
limited	O
.	O

The	O
subcutaneous	O
implantable	B:C0162589
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
(	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
)	O
has	O
emerged	O
as	O
a	O
novel	O
tool	O
for	O
prevention	O
of	O
sudden	O
cardiac	I:C0085298
death	I:C0085298
,	O
but	O
clinical	O
performance	I:C3266594
data	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
are	O
limited	O
.	O

The	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
(	O
implantable	B:C0162589
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
)	O
has	O
emerged	O
as	O
a	O
novel	O
tool	O
for	O
prevention	O
of	O
sudden	O
cardiac	I:C0085298
death	I:C0085298
,	O
but	O
clinical	O
performance	I:C3266594
data	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
are	O
limited	O
.	O

The	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
(	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
)	O
has	O
emerged	O
as	O
a	O
novel	O
tool	O
for	O
prevention	O
of	O
sudden	B:C0085298
cardiac	I:C0085298
death	I:C0085298
,	O
but	O
clinical	O
performance	I:C3266594
data	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
are	O
limited	O
.	O

The	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
(	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
)	O
has	O
emerged	O
as	O
a	O
novel	O
tool	O
for	O
prevention	O
of	O
sudden	O
cardiac	I:C0085298
death	I:C0085298
,	O
but	O
clinical	B:C3266594
performance	I:C3266594
data	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
are	O
limited	O
.	O

The	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
(	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
)	O
has	O
emerged	O
as	O
a	O
novel	O
tool	O
for	O
prevention	O
of	O
sudden	O
cardiac	I:C0085298
death	I:C0085298
,	O
but	O
clinical	O
performance	I:C3266594
data	O
for	O
adults	O
with	O
congenital	B:C0152021
heart	I:C0152021
disease	I:C0152021
are	O
limited	O
.	O

A	O
retrospective	B:C0035363
study	I:C0035363
involving	O
7	O
centers	O
over	O
a	O
5	O
-	O
year	O
period	O
beginning	O
in	O
2011	O
was	O
performed	O
.	O

The	O
most	O
common	O
diagnosis	B:C0011900
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	B:C0152424
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	B:C0031843
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	B:C1274136
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	B:C0190010
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	B:C0397538
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	B:C1275836
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	B:C1306542
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	B:C0339890
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	B:C0039685
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	B:C1260873
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	O
(	O
n=4	O
)	O
.	O

The	O
most	O
common	O
diagnosis	O
was	O
single	O
ventricle	I:C0152424
physiology	O
(	O
52	O
%	O
)	O
,	O
9	O
palliated	O
by	O
Fontan	O
operation	I:C0190010
and	O
2	O
by	O
aortopulmonary	O
shunts	I:C0397538
:	O
d-transposition	O
of	I:C1275836
the	I:C1275836
great	I:C1275836
arteries	I:C1275836
after	O
Mustard	O
/	O
Senning	O
(	O
n=2	O
)	O
,	O
tetralogy	O
of	I:C0039685
Fallot	I:C0039685
(	O
n=2	O
)	O
,	O
aortic	O
valve	I:C1260873
disease	I:C1260873
(	O
n=2	O
)	O
,	O
and	O
other	O
biventricular	O
surgery	B:C0543467
(	O
n=4	O
)	O
.	O

A	O
prior	O
cardiac	B:C0018825
device	I:C0018825
had	O
been	O
implanted	O
in	O
7	O
(	O
33	O
%	O
)	O
.	O

A	O
prior	O
cardiac	O
device	I:C0018825
had	O
been	O
implanted	B:C0948629
in	O
7	O
(	O
33	O
%	O
)	O
.	O

The	O
implantable	B:C0162589
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
indication	O
was	O
primary	O
prevention	I:C0033144
in	O
67	O
%	O
and	O
secondary	O
in	O
33	O
%	O
patient	O
s.	O

The	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
indication	O
was	O
primary	B:C0033144
prevention	I:C0033144
in	O
67	O
%	O
and	O
secondary	O
in	O
33	O
%	O
patient	O
s.	O

The	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
indication	O
was	O
primary	O
prevention	I:C0033144
in	O
67	O
%	O
and	O
secondary	B:C0679699
in	O
33	O
%	O
patient	O
s.	O

The	O
most	O
common	O
reason	O
for	O
subcutaneous	B:C0443315
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
was	O
limited	O
transvenous	O
access	I:C0522521
for	O
ventricular	O
lead	I:C2825199
placement	O
(	O
n=10	O
)	O
followed	O
by	O
intracardiac	O
right	I:C0489644
-	I:C0489644
to	I:C0489644
-	I:C0489644
left	I:C0489644
shunt	I:C0489644
(	O
n=5	O
)	O
.	O

The	O
most	O
common	O
reason	O
for	O
subcutaneous	O
implantable	B:C0162589
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
was	O
limited	O
transvenous	O
access	I:C0522521
for	O
ventricular	O
lead	I:C2825199
placement	O
(	O
n=10	O
)	O
followed	O
by	O
intracardiac	O
right	I:C0489644
-	I:C0489644
to	I:C0489644
-	I:C0489644
left	I:C0489644
shunt	I:C0489644
(	O
n=5	O
)	O
.	O

The	O
most	O
common	O
reason	O
for	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	B:C0441587
was	O
limited	O
transvenous	O
access	I:C0522521
for	O
ventricular	O
lead	I:C2825199
placement	O
(	O
n=10	O
)	O
followed	O
by	O
intracardiac	O
right	I:C0489644
-	I:C0489644
to	I:C0489644
-	I:C0489644
left	I:C0489644
shunt	I:C0489644
(	O
n=5	O
)	O
.	O

The	O
most	O
common	O
reason	O
for	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
was	O
limited	O
transvenous	B:C0522521
access	I:C0522521
for	O
ventricular	O
lead	I:C2825199
placement	O
(	O
n=10	O
)	O
followed	O
by	O
intracardiac	O
right	I:C0489644
-	I:C0489644
to	I:C0489644
-	I:C0489644
left	I:C0489644
shunt	I:C0489644
(	O
n=5	O
)	O
.	O

The	O
most	O
common	O
reason	O
for	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
was	O
limited	O
transvenous	O
access	I:C0522521
for	O
ventricular	B:C2825199
lead	I:C2825199
placement	O
(	O
n=10	O
)	O
followed	O
by	O
intracardiac	O
right	I:C0489644
-	I:C0489644
to	I:C0489644
-	I:C0489644
left	I:C0489644
shunt	I:C0489644
(	O
n=5	O
)	O
.	O

The	O
most	O
common	O
reason	O
for	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
was	O
limited	O
transvenous	O
access	I:C0522521
for	O
ventricular	O
lead	I:C2825199
placement	B:C0441587
(	O
n=10	O
)	O
followed	O
by	O
intracardiac	O
right	I:C0489644
-	I:C0489644
to	I:C0489644
-	I:C0489644
left	I:C0489644
shunt	I:C0489644
(	O
n=5	O
)	O
.	O

The	O
most	O
common	O
reason	O
for	O
subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
was	O
limited	O
transvenous	O
access	I:C0522521
for	O
ventricular	O
lead	I:C2825199
placement	O
(	O
n=10	O
)	O
followed	O
by	O
intracardiac	B:C0489644
right	I:C0489644
-	I:C0489644
to	I:C0489644
-	I:C0489644
left	I:C0489644
shunt	I:C0489644
(	O
n=5	O
)	O
.	O

Ventricular	B:C0085612
arrhythmia	I:C0085612
was	O
induced	O
in	O
17	O
(	O
81	O
%	O
)	O
and	O
was	O
converted	O
with	O
≤	O
80	O
Joules	O
in	O
all	O
.	O

There	O
was	O
one	O
implant	B:C0085073
complication	I:C0085073
related	I:C0085073
to	I:C0085073
infection	I:C0085073
,	O
not	O
requiring	O
device	O
removal	I:C0752250
.	O

There	O
was	O
one	O
implant	O
complication	I:C0085073
related	I:C0085073
to	I:C0085073
infection	I:C0085073
,	O
not	O
requiring	O
device	B:C0752250
removal	I:C0752250
.	O

Over	O
a	O
median	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
of	O
14	O
months	O
,	O
4	O
patients	O
(	O
21	O
%	O
)	O
received	O
inappropriate	O
and	O
1	O
(	O
5	O
%	O
)	O
patient	O
received	O
appropriate	O
shocks	I:C0036984
.	O

Over	O
a	O
median	O
follow	O
-	I:C1522577
up	I:C1522577
of	O
14	O
months	O
,	O
4	O
patients	O
(	O
21	O
%	O
)	O
received	O
inappropriate	B:C0340944
and	O
1	O
(	O
5	O
%	O
)	O
patient	O
received	O
appropriate	O
shocks	I:C0036984
.	O

Over	O
a	O
median	O
follow	O
-	I:C1522577
up	I:C1522577
of	O
14	O
months	O
,	O
4	O
patients	O
(	O
21	O
%	O
)	O
received	O
inappropriate	O
and	O
1	O
(	O
5	O
%	O
)	O
patient	O
received	O
appropriate	B:C0036984
shocks	I:C0036984
.	O

There	O
was	O
one	O
arrhythmic	O
death	O
related	O
to	O
asystole	B:C0018790
in	O
a	O
single	O
ventricle	I:C0152424
patient	O
.	O

There	O
was	O
one	O
arrhythmic	O
death	O
related	O
to	O
asystole	O
in	O
a	O
single	B:C0152424
ventricle	I:C0152424
patient	O
.	O

Subcutaneous	B:C0443315
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
implantation	O
is	O
feasible	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
patients	O
.	O

Subcutaneous	O
implantable	B:C0162589
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
implantation	O
is	O
feasible	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
patients	O
.	O

Subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
implantation	B:C0021107
is	O
feasible	O
for	O
adults	O
with	O
congenital	O
heart	I:C0152021
disease	I:C0152021
patients	O
.	O

Subcutaneous	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
implantation	O
is	O
feasible	O
for	O
adults	O
with	O
congenital	B:C0152021
heart	I:C0152021
disease	I:C0152021
patients	O
.	O

Most	O
candidates	O
have	O
single	B:C0152424
ventricle	I:C0152424
heart	O
disease	I:C0018799
and	O
limited	O
transvenous	O
options	I:C0522521
for	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
.	O

Most	O
candidates	O
have	O
single	O
ventricle	I:C0152424
heart	B:C0018799
disease	I:C0018799
and	O
limited	O
transvenous	O
options	I:C0522521
for	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
.	O

Most	O
candidates	O
have	O
single	O
ventricle	I:C0152424
heart	O
disease	I:C0018799
and	O
limited	O
transvenous	B:C0522521
options	I:C0522521
for	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
.	O

Most	O
candidates	O
have	O
single	O
ventricle	I:C0152424
heart	O
disease	I:C0018799
and	O
limited	O
transvenous	O
options	I:C0522521
for	O
implantable	B:C0162589
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	O
.	O

Most	O
candidates	O
have	O
single	O
ventricle	I:C0152424
heart	O
disease	I:C0018799
and	O
limited	O
transvenous	O
options	I:C0522521
for	O
implantable	O
cardioverter	I:C0162589
-	I:C0162589
defibrillator	I:C0162589
placement	B:C0441587
.	O

Despite	O
variable	O
anatomy	O
,	O
this	O
study	B:C2603343
demonstrates	O
successful	O
conversion	O
of	O
induced	O
ventricular	O
arrhythmia	I:C0085612
and	O
reasonable	O
rhythm	O
discrimination	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Despite	O
variable	O
anatomy	O
,	O
this	O
study	O
demonstrates	O
successful	O
conversion	O
of	O
induced	O
ventricular	B:C0085612
arrhythmia	I:C0085612
and	O
reasonable	O
rhythm	O
discrimination	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Despite	O
variable	O
anatomy	O
,	O
this	O
study	O
demonstrates	O
successful	O
conversion	O
of	O
induced	O
ventricular	O
arrhythmia	I:C0085612
and	O
reasonable	B:C0184784
rhythm	O
discrimination	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Despite	O
variable	O
anatomy	O
,	O
this	O
study	O
demonstrates	O
successful	O
conversion	O
of	O
induced	O
ventricular	O
arrhythmia	I:C0085612
and	O
reasonable	O
rhythm	B:C0232187
discrimination	O
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Despite	O
variable	O
anatomy	O
,	O
this	O
study	O
demonstrates	O
successful	O
conversion	O
of	O
induced	O
ventricular	O
arrhythmia	I:C0085612
and	O
reasonable	O
rhythm	O
discrimination	B:C0234412
during	O
follow	O
-	I:C1522577
up	I:C1522577
.	O

Despite	O
variable	O
anatomy	O
,	O
this	O
study	O
demonstrates	O
successful	O
conversion	O
of	O
induced	O
ventricular	O
arrhythmia	I:C0085612
and	O
reasonable	O
rhythm	O
discrimination	O
during	O
follow	B:C1522577
-	I:C1522577
up	I:C1522577
.	O

